Regis Healthcare reacts to government funding change

Regis Healthcare says government funding will rise just 2.55% as wage and cost inflation run much higher across the sector.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Regis Healthcare Ltd (ASX: REG) share price is in focus after the company noted only a 2.55% increase to the industry-wide government funding rate, with inflation and wage pressures running well ahead of this increase.

Couple looking ahead with laptop open at a table.

Image source: Getty Images

What did Regis Healthcare report?

  • The AN-ACC starting price will rise 2.55% from $295.64 to $303.19 per resident per day from 1 October 2026
  • The hotelling supplement will remain at $22.15 per resident per day
  • Government has kept the care minute requirements and funding categories unchanged
  • Recent cost drivers: 4.75% wage increase for award-based workers; up to 4.4% increase for nurses; 3.8% CPI growth

What else do investors need to know?

Regis Healthcare pointed out that the 2.55% funding uplift lags well behind sector cost growth, driven by higher wages and inflation. The annual wage review and recent Fair Work Commission decisions mean that wages for nurses and care staff are rising significantly faster than aged care government reimbursement.

The company reaffirmed its strategy to manage ongoing margin pressure, noting initiatives such as raising room prices, rolling out Higher Everyday Living Fee (HELF) services, and enhancing both revenue optimisation and operational efficiency.

What's next for Regis Healthcare?

Regis says it will continue advocating for adequate sector funding to support growing demand for residential aged care. Its ongoing strategy to mitigate rising costs includes service enhancements, pricing adjustments, and operational improvements.

The company remains focused on delivering high-quality care to its 10,000 residents and clients, supported by a 13,000-strong team, while navigating ongoing policy and inflationary challenges.

Regis Healthcare share price snapshot

Over the past 12 months, Regis Healthcare shares have declined 23%, trailing the S&P/ASX 200 Index (ASX: XJO), which has risen 3% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Healthcare Shares

A doctor looks unsure.
Healthcare Shares

CSL shares rebound 86%: Is the ASX biotech stock a buy, sell or hold for September?

Find out why investors are now rushing to buy CSL shares.

Read more »

A medical researcher wearing a white coat sits at her desk in a laboratory conducting a test.
Healthcare Shares

Could this 7%-yielding ASX healthcare share be a growth winner?

The current weakness could be catching the eye of passive income investors.

Read more »

Two scientists looking at a tablet.
Healthcare Shares

CSL shares are up more than 40% in a month. What just happened in the US?

The stock’s huge rebound is getting another boost.

Read more »

Woman flexes muscles after donating blood.
ASX Share Market News

Where will CSL shares be in 12 months? Brokers weigh in

Analysts remain divided over CSL’s recovery prospects.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Why this ASX healthcare share is a retiree's dream for FY27

This defensive business is giving investors rising dividends.

Read more »

Two scientists analysing results on a computer screen.
Broker Notes

Up 88%! Why CSL shares remain an 'appealing' buy today

A top analyst forecasts more outperformance from CSL’s surging shares.

Read more »

Two scientists analysing results on a computer screen.
Earnings Results

Monash IVF Group earnings: FY26 profit slips, outlook improves

The company posted weaker FY26 profit but ends year with improving momentum, dividend, and outlook for growth.

Read more »

Happy investor on tablet with finance graphs rising in overlay.
Healthcare Shares

Bell Potter says this ASX healthcare share could rise 200%+

The broker has good things to say about this growing stock.

Read more »